Pumarix

pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) · GlaxoSmithKline Biologicals S.A.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Pumarix, covering 2015-03-17 to 2015-03-17. Get the full timeline:

Most recent: EMA Withdrawn: Pumarix (pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted)) — GlaxoSmithKline Biologicals S.A.